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Phosphonates (C-PO3
2) have applications as antibi-
otics, herbicides, and detergents. In some environ-
ments, these molecules represent the predominant
source of phosphorus, and several microbes have
evolved dedicated enzymatic machineries for phos-
phonate degradation. For example, most common
naturally occurring phosphonates can be catabo-
lized to either phosphonoacetaldehyde or phospho-
noacetate, which can then be hydrolyzed to generate
inorganic phosphate and acetaldehyde or acetate,
respectively. The phosphonoacetaldehyde oxidase
gene (phnY) links these two hydrolytic processes
and provides a previously unknown catabolic mech-
anism for phosphonoacetate production in the
microbial metabolome. Here, we present biochem-
ical characterization of PhnY and high-resolution
crystal structures of the apo state, as well as com-
plexes with substrate, cofactor, and product. Kinetic
analysis of active site mutants demonstrates how a
highly conserved aldehyde dehydrogenase active
site has been modified in nature to generate activity
with a phosphonate substrate.
INTRODUCTION
Phosphonates are ubiquitous molecules characterized by the
presence of an inert carbon-phosphorus (C-PO3
2) bond in
contrast to a labile oxygen-phosphorus (O-PO3
2) bond found
in phosphoric esters. Phosphonates are nearly isosteric with
the corresponding phosphoric esters and preserve the tetra-
hedral geometry and net charge distribution around the
phosphorus atom, but are recalcitrant toward chemical and
enzymatic hydrolytic reactions that can cleave the more labileChemistry & Biology 21, 125O-PO3
2 bond. Thus, phosphonates can act as competitive in-
hibitors of biochemical processes that involve phosphoryl group
transfer reactions (Metcalf and van der Donk, 2009). Nature has
utilized this chemical mimicry for the development of several
natural product phosphonates that have potent antibiotic, herbi-
cidal, and other bio-inhibitory activities.
The stability of the C-PO3
2 bond renders phosphonate mole-
cules as reservoirs for carbon and phosphorus in various micro-
bial niches. To take advantage of these resources in nutrient
scarce environments, nature has evolved pathways for the
catabolism of reduced phosphorus compounds for their subse-
quent utilization as carbon and phosphate sources (McGrath
et al., 2013; Nair and van der Donk, 2011; Peck and van der
Donk, 2013). The genetic basis of utilization of phosphite by
marine Prochlorococcus (Martı´nez et al., 2012) and other bacte-
ria has been determined (Costas et al., 2001). Furthermore, the
biosynthesis of methylphosphonate by the marine bacterium
Nitrosopumilus maritimus (Metcalf et al., 2012) is postulated to
result in its utilization by thewidely distributed C-P lyase pathway
(Hove-Jensen et al., 2011, 2012; Kamat et al., 2011) leading to
production of methane in aerobic oceanic ecosystems. The
most widely occurring natural phosphonate, 2-aminoethyl phos-
phonate (2-AEP), is degraded by at least three other experimen-
tally characterized processes (Figure 1A) in addition to the C-P
lyase pathway. Phosphonoacetaldehyde (PnAA), produced by
transamination of 2-AEP, is enzymatically hydrolyzed to yield
acetaldehyde and inorganic phosphate (Pi; Morais et al., 2000).
Alternatively, 2-AEP can be hydroxylated and then oxidized to
yield glycine and Pi (McSorley et al., 2012; note that McSorley
and colleagues designate another enzyme as ‘‘PhnY’’ that is
unrelated to the PhnY enzyme described in this study). Further-
more, we have previously demonstrated the conversion of
2-AEP-derived PnAA to phosphonoacetate (PnA; Figure 1A,
box), which is then hydrolyzed by a PnA hydrolase enzyme
(PhnA) to yield acetate and Pi in the soil-dwelling bacterium Sino-
rhizobium meliloti 1021 (Borisova et al., 2011). Although the PnA
hydrolase activity had been characterized previously from many
different ecological niches (White and Metcalf, 2007), the–135, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 125
Figure 1. Phosphonate Degradation Path-
ways
(A) Three enzymatic pathways for the breakdown
of PnAA. Top: PnAA hydrolysis to acetaldehyde
and Pi. Middle: PnAA-derived 2-AEP is hydroxyl-
ated and oxidized to yield glycine and Pi. Bottom:
oxidation of PnAA by PhnY (boxed) and subse-
quent hydrolysis by PhnA to yield acetate and Pi.
(B) Chemical structures of 3-OPP and G3P.
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enzyme PhnY established PnA to be a biogenic phosphonate.
NADP+-dependent PnAA dehydrogenation activity was also re-
ported in the cell extracts of the marine bacterium Roseovarius
nubinhibens ISM (Cooley et al., 2011). Bioinformatic analysis
demonstrates that 2-AEP degradation pathways involving
PhnY homologs are present across many different bacterial spe-
cies and ecological niches (Borisova et al., 2011; Cooley et al.,
2011; Kim et al., 2011).
PnAA is a common intermediate in various phosphonate
biosynthetic pathways and is produced by the enzymatic decar-
boxylation of phosphonopyruvate (Zhang et al., 2003). PnAA is
then transaminated to generate 2-AEP (Kim et al., 2002);
reduced to generate 2-hydroxyethyl phosphonate in dehydro-
phos, phosphinothricin, and fosfomycin biosynthesis (Peck
et al., 2012; Shao et al., 2008; Woodyer et al., 2007); or
condensed with oxaloacetate to generate 2-keto-4-hydroxy-5-
phosphonopentanoic acid in rhizocticin biosynthesis (Borisova
et al., 2010). PhnY provides a biogenic source for PnA in the mi-
crobial metabolome, allowing utilization of a common biological
phosphonate, PnAA, as a growth source.
Here, we present detailed biochemical and crystallographic
characterization of the PhnY enzyme from S. meliloti 1021
(henceforth referred to as PhnY). Crystal structures of the
enzyme and kinetic analysis of site-specific mutants establish
that PhnY bears structural and mechanistic similarity to the
aldehyde dehydrogenase superfamily of enzymes. We demon-
strate that PhnY is broadly substrate tolerant and can accept
3-oxopropyl phosphonate (3-OPP, or phosphonopropionalde-
hyde) and glyceraldehyde-3-phosphate (G3P) as substrates
(Figure 1B). The crystal structure of PhnY in the presence of
G3P leads to the postulate that PhnY does not discriminate
between phosphonates and phosphate-esters, but rather that
the physical dimension of the enzyme active site, comprised
of various basic residue side chains, modulates substrate
preference.
RESULTS
Overall Structure of PhnY
The structure of PhnY was determined in the apo state to 2.1 A˚
resolution. Crystallographic phases were determined by single
wavelength anomalous diffraction (relevant data collection sta-
tistics are provided in Table 1). The crystallographic asymmetric126 Chemistry & Biology 21, 125–135, January 16, 2014 ª2014 Elsevier Ltd All rights reserveunit consists of eight protein chains
comprising four sets of biologically rele-
vant homodimers (Figures 2A and 2B).
The arrangement of protein chains assets of homodimers is consistent with the behavior of PhnY as
a dimer in solution, as judged by size exclusion chromatography.
Each PhnY monomer shows architectural similarities to other
members of the nonphosphorylating aldehyde dehydrogenase
(ALDH) superfamily (Figure 2A). Residues 1–123, 147–256, and
461–475 together constitute the ‘‘cofactor-binding domain’’
and adopt a classical a/b Rossmann fold. Residues 257–460
form the ‘‘catalytic domain’’ with a distinct a/b fold comprised
of seven central b strands flanked by a helices on either
side. Residues 124–146, together with residues 476–486, consti-
tute the three-membered antiparallel b sheet ‘‘oligomerization
domain’’ that provides the principal contacts for dimerization
(Figure 2B). The loops at the interface of the cofactor-binding
domain and the catalytic domain provide nearly all the residues
implicated in substrate binding and catalysis (vide infra).
In the structure of the unliganded enzyme, electron density
corresponding to a phosphate ion (presumably from the crystal-
lization medium) is observed at the interface of the cofactor
binding and catalytic domains. The phosphate oxygen atoms
are coordinated by hydrogen bonds with the side chains of
His159, Arg290, Thr292, and Arg447 (Figure 2C). The Arg108
side chain, which is near the phosphate-binding site, shows
alternative conformations throughout the different molecules in
the asymmetric unit. In one conformation, Arg108 points toward
the phosphate binding-pocket with the guanidino group within
interaction distance with the phosphate. In the alternate confor-
mation, this residue points away from the active site and is sta-
bilized by interactions with the side chain of Asp111. This basic,
phosphate-binding pocket is strictly conserved among ALDHs
that catalyze oxidation of phosphorylated substrates, but is
missing in ALDHs that function on non-phosphorylated sub-
strates (Figure S1 available online).
Cocrystal Structure with the Physiological Phosphonate
Substrate PnAA
The 2.1 A˚ resolution cocrystal structure of PhnY in complex with
PnAA shows unambiguous density for the ligand in the active site
of all eight copies in the crystallographic asymmetric unit (Fig-
ure 3A). PnAA is bound at the interface of the cofactor-binding
and catalytic domains. The side chain thiol of Cys291 undergoes
a 120 rotation relative to the apo structure, which positions the
Cys291 side chain for interactions with the substrate. The
Cys291-Sg atom in this conformation is 3.0 A˚ and 3.3 A˚ away
from the backbone amide nitrogen atoms of Cys291 andd
Table 1. Data Collection, Phasing, and Refinement Statistics
PhnY-apo PhnY-PnAA PhnY-PnAA-NAD+ PhnY-PnA-NAD+ PhnY-G3P-NAD+
Data collection
a, b, c (A˚), b () 95.72, 172.79, 142.58,
107.57
93.35, 172.88, 138.97,
106.73
94.74, 172.13, 140.05,
107.75
95.16, 172.77, 142.60,
107.28
94.45, 172.70, 139.77,
106.90
Wavelength (A˚) 0.97856 0.97872 0.97856 0.97856 0.97872
Resolution (A˚)a 50.00–2.10 (2.20–2.10) 50.00–2.10 (2.20–2.10) 40.00–2.00 (2.03-2.00) 50.00–2.07 (2.11-2.07) 40.00–2.25 (2.29–2.25)
Total reflections 994,116 585,836 1,922,065 1,709,837 893,695
Unique reflections 246,726 236,736 286,921 250,280 198,176
Rsym (%) 12.1 (55.0) 9.8 (53.6) 12.7 (84.3) 7.0 (51.6) 10.9 (43.1)
I/s (I) 7.5 (1.6) 9.4 (1.65) 18.3 (2.4) 18.8 (2.1) 12.1 (2.0)
Completeness (%) 96.1 (87.9) 96.5 (90.3) 99.9 (99.6) 94.1 (74.9) 97.3 (96.3)
Redundancy 4.0 (2.4) 2.5 (1.8) 6.7 (6.2) 6.8 (4.7) 4.5 (3.7)
Refinement
Resolution (A˚) 24.87–2.10 39.11–2.10 39.50–2.00 28.58–2.07 24.97–2.25
No. reflections used 234,253 224,891 272,514 237,960 188,026
Rwork/Rfree
b 19.8/23.7 21.0/25.2 18.2/23.0 18.1/21.7 20.4/24.9
Number of atoms
Protein 29,144 29,008 29,008 29,163 29,008
Ligand 40 56 56 64 80
Cofactor – – 189 352 197
Water 2,329 1,916 2,571 2,861 1,678
B-factors
Protein 32.80 24.32 26.69 27.08 24.36
Ligand 35.21 21.84 25.81 37.96 33.94
Cofactor ligand – – 32.28 32.66 36.62
Water 37.88 28.51 32.73 34.23 27.13
Rmsd
Bond lengths (A˚) 0.009 0.016 0.008 0.012 0.014
Bond angles () 1.147 1.567 1.153 1.429 1.342
Rmsd, root-mean-square deviation.
aHighest resolution shell is shown in parentheses.
bR-factor = S(jFobsjkjFcalcj)/S jFobsjand R-free is the R value for a test set of reflections consisting of a random 5% of the diffraction data not used in
refinement.
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in modulating the nucleophilicity of the Cys side chain for nucle-
ophilic attack in related members of the ALDH superfamily
(Cobessi et al., 2000).
Strong and continuous electron density can be observed be-
tween the Cys291-Sg and the PnAA-Cb atom (at a distance of
1.8 A˚), indicative of a covalent bond between these two atoms.
Unbiased difference Fourier electron density maps are indicative
of tetrahedral geometry at the PnAA-Cb atom that is covalently
bound to the Cys291 sulfur atom (Figure 3A; Figure S2).
This tetrahedral geometry is presumably generated by nucleo-
philic attack of the Cys291-Sg thiolate at the Re face of planar
PnAA to generate a tetrahedral thiohemiacetal intermediate
with an (R) stereochemical configuration. Consequently, we
have modeled the substrate in the PhnY-PnAA binary complex
as a thiohemiacetal instead of an aldehyde.
The oxygen atom of the thiohemiacetal intermediate is posi-
tioned 3.1 A˚ away from the amide side chain of Asn158, and
3.2 A˚ away from the main chain amide nitrogen atom ofChemistry & Biology 21, 125Cys291 (Figure 3A). By analogy to the serine/cysteine protease
reaction mechanism (Hedstrom, 2002), these two interactions
constitute the ‘‘oxyanion hole’’ that stabilizes the tetrahedral
intermediate. Binding of PnAA orders the side chain of Arg108
in a solitary conformation pointing toward the active site, such
that the guanidine moiety now also interacts with the phospho-
nate oxygen atoms.
Cocrystal Structure of Ternary Complex with Substrate
PnAA and Cofactor NAD+
In the 2.0 A˚ resolution PhnY-NAD+-PnAA ternary complex, un-
ambiguous electron density can be observed for all atoms of
PnAA. However electron density is absent for the nicotinamide
ring and the adjoining ribose of the cofactor. Hence, only the
adenine diphosphate (ADP) moiety of the cofactor has been
modeled in the final structure (Figure 3B).
The substrate PnAA in the PhnY-NAD+-PnAA ternary complex
is positioned analogously to the thiohemiacetal intermediate
described previously, with all the interactions with the side–135, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 127
Figure 2. Overall Three-Dimensional Crys-
tal Structure of PhnY
(A and B) Structure of the PhnY (A) monomer and
(B) homodimer showing the relative positions of
the three domains with one monomer colored
gray, and the second monomer colored with the
cofactor binding and catalytic domains in blue,
and the oligomerization domain in pink. Cofactor
NAD+ is shown in ball-and-stick representation
with carbon atoms colored yellow.
(C) Stereo view showing the active site features of
PhnY in complex with Pi. The PhnY carbon atoms
are shown in yellow ball-and-stick representation.
Superimposed is a difference Fourier electron
densitymap (contouredat 2.7sover background in
blue, and 6.0s in red) calculated with coefficients
jFobsj  jFcalcj and phases from the final refined
modelwith the coordinates of thePideleted prior to
one round of refinement.
See also Figure S1.
Chemistry & Biology
Structure and Mechanism of PhnYchains of Asn158, His159, Arg108, Arg290, Thr292, and Arg447
conserved. However, the Fo  Fc difference electron density
map is indicative of planar geometry around the PnAA-Cb
atom (Figure 3B; Figure S2). This planar geometry presumably
arises due to the transfer of the hydride from the PnAA-Cb to
the cofactor, and the concomitant conversion of the tetrahedral
thiohemiacetal intermediate to a sp2 hybridized planar thioester.
The bond angles around the PnAA-Cb have thus been refined to
a planar geometry. Variability is observed in the positioning of the
Glu254 side chain near the thioester intermediate. Based on
sequence homology (Figure S1), this residue is the catalytic
base that primes a water molecule for nucleophilic attack on
the thioester intermediate that is generated in the catalytic cycle
for PhnY (vide infra). In some polypeptide chains, the Glu254 side
chain points toward the thioester (chains A, B, and H), while it
points away from the thioester in other chains (chains C, D, E,
F, and G), without stabilizing interactions for the Glu254 side
chain carboxylate in either of the two conformations. This lack
of interaction for the Glu254 side chain is reflected in the signif-
icantly higher B-factors for the Glu254 side chain atoms (51.1 A˚2)
as compared to the Glu254 main chain atoms (23.0 A˚2). Incuba-
tion of a mutant of PhnY in which Glu254 was mutated to Ala re-
sulted in suppressed deacylation activity allowing the detection
of a covalent intermediate by electrospray mass spectrometry
(Figure S3). The resolution of the mass spectrum did not allow128 Chemistry & Biology 21, 125–135, January 16, 2014 ª2014 Elsevier Ltd All rights reservedistinction between the thiohemiacetal
or thioester, but the higher chemical
stability of the latter suggests that the
trapped intermediate corresponds to the
thioester.
Structure of the Ternary Complex
with NAD+ and PnA
The 2.1 A˚ resolution cocrystal structure of
PhnY in complex with NAD+ and PnA
shows clear and continuous density for
the entire cofactor in all copies in the crys-
tallographic asymmetric unit (Figure 3C;
Figures S4 and S5). The adenine ring ofNAD+ is positioned in a hydrophobic pocket defined by the
side chains of Pro214, Phe232, Val238, Leu241, and Ile242
(Figure S4). The adenine ribose sugar hydroxyls are stabilized
by interactions with Lys181. The 20 hydroxyl makes additional
contacts with Glu184, while the 30 hydroxyl contacts the back-
bone carbonyl of Thr155. The Glu184 side chain likely dictates
the specificity of PhnY for NAD+ as the cofactor (Borisova
et al., 2011) because the additional phosphate group in NADP+
would clash with the Glu184 side chain. The pyrophosphate moi-
ety of NAD+makes hydrogen bondswith themain chain atoms of
Ser235 and Phe157, and a water-mediated hydrogen bond with
the Thr183 side chain. Hydrogen bonds with the side chain of
Glu385 provide the only interaction for the nicotinamide ribose
hydroxyl groups. The Cys291-Sg is positioned at the Re-face
of C4 of the nicotinamide ring. The Si face of the nicotinamide
ring is buttressed by the side chain of Thr233. The only interac-
tions with the nicotinamide ring amide are two water-mediated
hydrogen bonds with the side chain of Glu465 and the main
chain amide nitrogen of Gly455. This relative lack of interactions
manifests itself as higher B-factors for the adenine and nicotin-
amide rings of the cofactor, as compared to the rest of the
molecule (Figure S5). A comparative decrease in conformational
ordering of the cofactor, starting from the adenine to the nicotin-
amide terminus of NAD+, is evident in the quality of the difference
in electron density maps (Figure 3C).d
Figure 3. PhnY Active Site in Complex
with Substrate PnAA, Product PnA, and
Cofactor NAD+
All atoms are shown in ball-and-stick representa-
tion with PhnY side chain carbon atoms colored
yellow, and PnAA, PnA, and NAD+ carbon atoms
colored green.
(A) See also Figure S2. Stereo view showing the
active site features of PhnY in the binary complex
with the substrate PnAA. Superimposed is a dif-
ference Fourier electron densitymap (contoured at
2.5s over background in blue) calculated as
before. Stabilizing interactions of PnAA with PhnY
are shown as black dashes.
(B) See also Figure S3. Stereo view of the PhnY
active site in the ternary complex with substrate
PnAA and cofactor NAD+. Superimposed is the
difference electron density map contoured at 2.5s
over background in blue, calculated as before.
Note that the nicotinamide and ribose rings for the
cofactor have not been modeled.
(C) See also Figures S4 and S5. Stereo view of
the PhnY active site in the ternary complex with
product PnA and cofactor NAD+. Superimposed is
a difference Fourier electron density map (con-
toured at 2.5s over background in blue,) calcu-
lated as before. Stabilizing interactions for NAD+
are described in Figure S4. Note the presence of
the nicotinamide ring and the ribose sugar.
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within the active site (Figure 3C). However, no covalent bond
exists between Cys291-Sg and PnA-Cb atoms, evident from
the lack of continuous electron density. One of the PnA carbox-
ylate oxygen atoms is within hydrogen bonding distance to the
main chain amide nitrogen of Cys291 (3.0 A˚) and the side chain
imidazole Nε2 nitrogen atom of His159 (3.3 A˚). The other PnA
carboxylate oxygen atom is bereft of any interactions with the
polypeptide.
Kinetic Analysis of the Wild-Type and Site-Directed
Mutants of PhnY
Using the complex structures as guides, we generated site-
specific PhnY mutants, and characterized their kinetic behavior.
Kinetic characterization of the wild-type and variants enzymes
were carried out as described previously (Borisova et al.,
2011). For the wild-type enzyme, the kinetic parameters deter-
mined in this study, kcat = 2.2 ± 0.1 s
1 and KM = 3.2 ± 0.7 mM
for PnAA, are in good agreement with the previously published
values (Table 2; Figure S6; Borisova et al., 2011).
No activity was observed when either Cys291 or Glu254 was
replaced by Ala, confirming the vital roles each plays in catalysis.
The Asn158Ala mutation resulted in a 200-fold decrease in kcat.Chemistry & Biology 21, 125–135, January 16, 2014Replacement of Arg108 by Ala led to a
40-fold decrease in kcat and a 3-fold in-
crease in KM,PnAA, and the Arg290Ala
mutation resulted in a similar 20-fold
decrease in kcat with a slightly elevated
KM,PnAA relative to wild-type. The
Arg447Ala mutation reduced the kcat 30-
fold and increased the KM,PnAA 50-fold.Glu385 provides the only interaction with the nicotinamide ribose
20 and 30 hydroxyl groups; the Glu385Ala mutation resulted in a
10-fold reduction in kcat, with an approximately 6-fold higher
KM,NAD+.
Kinetics and Ternary Complex Structures of PhnY-NAD+
with Nonphysiological Substrates 3-OPP and G3P
The active site of PhnY is highly similar to glyceraldehyde-
3-phosphate dehydrogenase (GAPDH) from Streptococcus
mutans, a well-characterized enzyme of primary metabolism
that catalyzes the conversion of G3P to 3-phosphoglycerate. A
one-to-one mapping of active site side chains was observed,
with the exception of GAPDH-Tyr155 being changed to His159
in PhnY. To explore whether this structural similarity between
the two active sites translates to substrate promiscuity for
PhnY, we explored the activity of PhnY with G3P, the physiolog-
ical substrate of GAPDH.We additionally chemically synthesized
a one-carbon atom longer mimic of PnAA, 3-OPP (Figure 1B).
PhnY could indeed accept G3P and 3-OPP as substrates.
Oxidation of 3-OPP by PhnY proceeded with nearly identical
kcat, but a 1000-fold increase in KM compared to the KM for
PnAA (Table 2). However, the oxidation of G3P proceeded with
a 20-fold reduction in kcat for the enzyme and a 30-fold increaseª2014 Elsevier Ltd All rights reserved 129
Table 2. Steady-State Kinetic Parameters for Various PhnY
Constructs and WT GAPDH
KM,Pn (mM) KM,NAD+ (mM) kcat (s
1)
PhnY constructs with PnAA
Wild-type 3.2 ± 0.7 58 ± 9 2.2 ± 0.1
Arg108Ala 9.7 ± 0.8 18 ± 2 0.051 ± 0.001
Asn158Ala 29 ± 9 40 ± 6 0.010 ± 0.001
Glu254Ala ND ND ND
Arg290Ala 5.1 ± 0.6 75 ± 8 0.12 ± 0.003
Cys291Ala ND ND ND
Glu385Alaa 19 ± 3 370 ± 10 0.19 ± 0.03
Arg447Ala 150 ± 20 54 ± 1 0.076 ± 0.003
PhnY constructs with G3P
Wild-type 97 ± 7 530 ± 50 0.098 ± 0.003
Cys291Ala ND ND ND
PhnY constructs with 3-OPP
Wild-type 3,300 ± 100 ND 1.5 ± 0.1
Cys291Ala ND ND ND
GAPDH with various substrates
PnAA ND ND ND
3-OPP 1,500 ± 300 330 ± 20 0.038 ± 0.022
G3P (racemic) 25 ± 7 22 ± 1 22 ± 2
ND, not determined. Low levels of detectable activity precluded kinetic
parameter determination.
aThis mutant displayed substrate inhibition (see Figure S6); the Ki,PnAA
was 420 ± 70 mM.
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for the PhnY Cys291Ala mutant enzyme using either 3-OPP
or G3P.
The crystal structure of the PhnY-G3P-NAD+ ternary complex,
determined to a limiting resolution of 2.25 A˚, reveals truncated
density for the cofactor analogous to the PhnY-PnAA-NAD+
crystal structure described previously. The G3P-Cg atom is
covalently bonded to the Cys291-Sg side chain. The geometry
around the G3P-Cg atom is indicative of planar sp2 hybridization
(Figure 4A; Figure S8). The thioester oxygen atom is 3.2 A˚ away
from the side chain amide of Asn158, and 3.0 A˚ away from the
main chain amide nitrogen of Cys291. In most PhnY monomers,
the G3P-Cb hydroxyl makes a water mediated hydrogen-
bonding contact with the side chain of Glu465. No interactions
are present for the G3P bridging oxygen of the phosphate ester.
The side chain of Glu254 points away from the thioester interme-
diate in all polypeptides within the asymmetric unit.
In the PhnY-G3P-NAD+ ternary complex, the side chains of
Arg108, His159, Arg290, and Arg447 bind the phosphoryl oxy-
gen atoms of G3P, in a manner analogous to PnAA (Figures 4A
and 4B). These interactions are analogous to the interactions
of G3P within the GAPDH active site, which are provided
by the corresponding GAPDH residues, which are Arg103,
Tyr155, Arg283, and Arg437 (Figure 4C). Direct interactions for
the bridging phosphoryl ester oxygen atom of G3P, mediated
by GAPDH residues Arg437 and Tyr155 (red dashed lines in Fig-
ure 4C), are absent in PhnY. However, there are no residues
in the PhnY active site that would occlude phosphorylated
substrates.130 Chemistry & Biology 21, 125–135, January 16, 2014 ª2014 ElsevDISCUSSION
Prior work has led to the characterization of a novel pathway for
phosphonate degradation in S. meliloti 1021, which utilizes PhnY
to convert PnAA to PnA (Borisova et al., 2011). Oxidation of PnAA
primes the resultant carboxylic acid for subsequent enzymatic
hydrolysis by PhnA (Agarwal et al., 2011; Cooley et al., 2011;
Kim et al., 2011). PhnY provides an intriguing biochemical basis
for the synthesis of PnA in the microbial metabolome.
The structural data presented here demonstrate that PhnY
belongs to the family of CoA-independent non-phosphorylating
aldehyde dehydrogenases. Structural comparisons with other
ALDHs reveal how minor changes in a highly conserved ALDH
active site can increase the repertoire for this class of enzymes
to include phosphonate substrates, and expand upon the role
of ALDHs in the biodegradation and bioremediation of inert
molecules.
Model for Productive Hydride Transfer Conformation for
the Cofactor
Our efforts at obtaining a ternary complex of wild-type PhnYwith
PnAA and NAD+ resulted in only partial electron density for the
cofactor (Figure 3B), with density for the hydride acceptor nico-
tinamide ring and the adjoining ribose missing. Truncated den-
sity for the cofactor was also observed in the PhnY-G3P-NAD+
ternary complex crystals (Figure 4A). Soaking the PhnY-PnAA-
NAD+ crystals with excess of NAD+ for up to 2 days also did
not result in increased occupancy of the cofactor nicotinamide
ring. However, a complete description of the cofactor was
achieved in the PhnY-PnA-NAD+ ternary complex (Figure 3C).
To describe the hydride transfer conformation of the cofactor,
we aligned the coordinates of the PhnY-PnAA binary complex,
with those of the PhnY-PnA-NAD+ ternary complex. An analysis
of the relative positioning of the C4 atom of the nicotinamide ring
(the hydride acceptor) and the PnAA-Cb atom (hydride donor)
leads us to propose that this model represents the experimen-
tally elusive hydride transfer conformation for PhnY (Figure 5A).
The nicotinamide C4 and PnAA-Cb atoms are positioned in prox-
imity to each other, with a distance of 2.1 A˚ between the two. The
tetrahedral geometry of the thiohemiacetal intermediate in the
PhnY-PnAA binary complex (Figure 3A; Figure S2) would thus
position the hydride for transfer to the C4 atom of the nicotin-
amide. It should be noted that in this model, the Glu254 side
chain is occluded from the active site due to steric clash with
the NAD+ nicotinamide ring (Figure 5A).
Proposed Catalytic Mechanism for PhnY Involving a
Flexible Cofactor
Three classes of ALDHs have been characterized, all of which
share a common first acylation half reaction that includes
hydride transfer to the cofactor. Variability is observed in the
second deacylation half reaction, based on the deacylating
nucleophile: hydroxyl anion, phosphate, or a coenzyme A
(CoA) thiolate. Our understanding of the CoA-independent non-
phosphorylating ALDHs is based primarily on the extensive
structural and mechanistic characterization of GAPDH (Cobessi
et al., 2000; D’Ambrosio et al., 2006;Marchal and Branlant, 1999;
Marchal et al., 2000). Based on the PhnY cocrystal structures
and kinetic data presented in this study and the structuralier Ltd All rights reserved
Figure 4. Ternary Complex of PhnY with
G3P and Truncated Cofactor NAD+
(A) Stereo view of G3P and NAD+ binding to PhnY.
All atoms are colored as before. Superimposed is
the difference electron density map contoured at
2.5s in blue, calculated as before.
(B and C) Interactions are shown as green dashes
for the binding of (B) G3P with PhnY, and (C) G3P
with GAPDH. G3P bonds are colored purple, and
enzyme residue bonds are colored brown. The
interactions for the G3P phosphoryl oxygen atom
and Cb hydroxyl, which are absent in PhnY, are
shown in red dashes. Note the different confor-
mations of G3P in the PhnY active site and GAPDH
active site. Figure was generated by LigPlot+
(Laskowski and Swindells, 2011) using refined
coordinates of PhnY-G3P-NAD+ complex for (B),
and PDB 2ESD for (C).
See also Figure S8.
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proposal for the conversion of PnAA to PnA by PhnY is shown
in Figure 5B.
In the acylation half reaction, PnAA is covalently bound to the
side chain of Cys291 forming a (R)-thiohemiacetal intermediate
at the interface of the catalytic and cofactor binding domains.
Residues Arg108, His159, Arg290, Thr292, and Arg447 coordi-
nate phosphoryl oxygen atoms. The side chain of Asn158 and
main chain amide nitrogen of Cys291 constitute the ‘‘oxyanion
hole’’ to stabilize the intermediate. The cofactor is aptly posi-
tioned for hydride transfer from the thiohemiacetal to the C4 car-
bon atom of the nicotinamide ring from the Re-face (Figure 5A),
generating a thioester intermediate. The hydride transfer confor-
mation of the cofactor occludes the side chain of Glu254 from
approaching the active site, due to steric clash between the
Si-face of the nicotinamide ring and the Glu254 side chain (Fig-
ure 5A; Figure S7). Following hydride transfer, the reduced nico-
tinamide departs from the active site, not necessarily involving
release of the cofactor by the cofactor-binding domain. In the
succeeding deacylation half reaction, the side chain of Glu254
is now positioned close to the thioester intermediate to deproto-
nate a water molecule for nucleophilic attack at the thioester.
This attack leads to the formation of a thioorthoester intermedi-
ate, which is resolved by the departure of the Cys291 side chain
and generation of the product PnA.
In the proposed reaction mechanism, the reduced cofactor
is not released from the enzyme prior to deacylation, but rather
the nicotinamide ring ‘‘flips-out’’ from the enzyme active site
to adopt alternate conformations, as has been proposed for
the GAPDH enzyme (D’Ambrosio et al., 2006). This allows for
the proper positioning of the catalytic base (Glu254 for PhnY),
which is required for the deacylation half reaction to occur. At
least four different conformations of the cofactor have been
structurally described in the literature (Cobessi et al., 2000;
D’Ambrosio et al., 2006; Langendorf et al., 2010; Perez-MillerChemistry & Biology 21, 125–135, January 16, 2014and Hurley, 2003). A conserved feature
of all these cofactor conformations is the
relatively higher thermal (B) factors for
the nicotinamide ring and the ribose sugarattached to the nicotinamide ring, and lower B values for the
ribose sugar bound to the adenine ring, and the pyrophosphate
moiety, as also observed in this study (Figure S5). This increase
in B-values is also accompanied by a relative reduction in
occupancy for the nicotinamide ring of the cofactor in these
examples.
Relaxed Substrate Specificity of PhnY and Evolution of
Enzyme Function in the ALDH Family
The active sites of PhnY and GAPDH are strikingly similar, apart
from the replacement of GAPDH-Tyr155 by PhnY-His159. To
determine whether this similarity in active sites would lead to
substrate promiscuity within the ALDH superfamily, we sought
to determine whether PhnY could use G3P as a substrate and
whether GAPDH could accept phosphonate substrates. GAPDH
oxidized 3-OPP with a large decrease in catalytic efficiency,
and the rate of PnAA oxidation was below the detection limit
(Table 2). In comparison, G3P was a better substrate for PhnY,
albeit with a 20-fold reduction in kcat as compared to GAPDH
(Marchal et al., 2000).
The observed reduction in the catalytic efficiency of G3P
oxidation by PhnY as compared to GAPDH may be a result of
unfavorable electrostatic interactions. In the PhnY-G3P-NAD+
ternary complex (Figures 4A and 4B), G3P is contorted so that
the thiohemiacetal oxyanion is positioned only 2.9 A˚ away from
one of the phosphoryl oxygen atoms. On the other hand for the
GAPDH-G3P-NAD+ ternary complex (Figure 4C; Protein Data
Bank [PDB]: 2ESD; D’Ambrosio et al., 2006), G3P is fully
extended and the corresponding thiohemiacetal oxyanion does
not have such destabilizing electrostatic repulsions from the
phosphoryl oxygen atoms. Thus, the physical dimensions of
the PhnY and GAPDH active sites seem to dictate substrate
specificities. A larger GAPDH active site allows for G3P to be fully
extended in the GAPDH active site while a smaller PhnY active
site distorts G3P so that the thiohemiacetal intermediate isª2014 Elsevier Ltd All rights reserved 131
Figure 5. AModel for Productive Hydride Conformation of the Cofactor and a ProposedMechanistic Scheme for Conversion of PnAA to PnA
by PhnY
(A) The coordinates for Cys291 and PnA were omitted from the PhnY-PnA-NAD+ ternary complex crystal structure and replaced with those of Cys291-PnAA
thiohemiacetal from the PhnY-PnAA binary complex crystal structure. The cofactor is shown in ball-and-stick representation with carbon atoms colored blue, and
carbon atoms for PnAA are colored green. The hydride donor PnAA-Cb and the hydride acceptor nicotinamide-C4 atoms are labeled. Black dashes represent
the ‘‘oxyanion hole’’ stabilizing interactions for the thiohemiacetal intermediate.
(B) Substrate binding interactions with the enzyme side chains are shown as black dashes. The reaction intermediates are shown in blue. The cofactor atoms are
shown in red. The relative geometric positions of the hydride and alkoxide of the thiohemiacetal intermediate, and the hydroxyl and alkoxide in the thioorthoester
intermediate are inferred from the crystal structures as shown in Figure 3A.
See also Figure S7.
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Structure and Mechanism of PhnYbound in an energetically less favorable conformation. In addi-
tion, the hydroxyl group in G3P makes contact with the side
chain of Arg437 in GAPDH, whereas this contact is absent in
the ternary complex of PhnY with G3P and cofactor.
A second postulate for the reduction in G3P oxidation activity
by PhnY is provided by the orientation of the Glu254 side chain
for the deacylation half reaction. In the PhnY-G3P-NAD+ ternary
complex, the Glu254 side chain is occluded away from the thio-
ester in all copies in the asymmetric unit. However, Glu254
shows variable positioning within the PhnY-PnAA-NAD+ ternary
complex. Superimposing the two structures reveals that the pro-
ductive deacylation orientation of Glu254 in the PhnY-G3P-
NAD+ ternary complex is occluded by the G3P-Cb hydroxyl
due to a steric clash (Figure S8). This in turn hinders the deacy-132 Chemistry & Biology 21, 125–135, January 16, 2014 ª2014 Elsevlation half reaction, which is rate limiting for GAPDH (Marchal
et al., 2000).
To test these two postulates, we synthesized 3-OPP and
determined the kinetic parameters for its oxidation by PhnY
and GAPDH. In 3-OPP the aldehyde is separated from the phos-
phoryl moiety by onemore bond than in PnAA, but one bond less
than in G3P. PhnY could indeed accept 3-OPP as a substrate.
As expected, the kcat for 3-OPP oxidation is comparable to
that for PnAA as the rate-limiting deacylation step is not hin-
dered, in contrast to G3P (Marchal et al., 2000). However, the
KM for 3-OPP oxidation is 1,000-fold greater than that for PnAA
(Table 2). This observation lends credence to the postulate that
substrates larger than PnAA will be unfavorably accommodated
within the constrained PhnY active site. This preference is notier Ltd All rights reserved
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nate. The lack of a hydroxyl group and a bridging oxygen on
3-OPP and the interactions they make with active site residues
may explain the greatly reduced catalytic activity of GAPDH
toward this substrate compared to G3P. These results are reflec-
tive of the diversity in catalytic activities that can be built upon the
conserved ALDH superfamily structural core.
SIGNIFICANCE
The discovery of the NAD+-dependent phosphonoacetalde-
hyde dehydrogenase enzyme PhnY established a biogenic
origin for phosphonoacetate, an activated C-P bond-
containing compound that is used as a phosphorus and
carbon source in several microorganisms. The structural
and biochemical studies of PhnY presented here provide in-
sights into how the widely conserved aldehyde dehydroge-
nase active site can be adapted for phosphonate substrates.
The cocrystal structure of PhnYwith substrate phosphonoa-
cetaldehyde reveals an unusual observation of a thiohemia-
cetal intermediate depicted in an aldehyde dehydrogenase
superfamily enzyme.
EXPERIMENTAL PROCEDURES
Chemicals
G3P was obtained from Sigma-Aldrich (G5251-25MG) and used without
further purification. Media components were purchased from Thermo Fisher
Scientific or VWR. DNA primers were synthesized by Integrated DNA Technol-
ogies. Restriction enzymes were obtained from New England Biolabs. DNA
sequencing was performed by ACGT. Phosphonoacetaldehyde was freshly
prepared before use as described earlier (Borisova et al., 2011).
Cloning, Protein Expression, Purification, and Crystallization
Cloning, expression, and purification of recombinant PhnY from Escherichia
coli has been described previously (Borisova et al., 2011). The mutant con-
structs Arg108Ala, Asn158Ala, His159Ala, Glu254Ala, Arg290Ala, Cys291Ala,
Thr292Ala, Glu385Ala, and Arg447Ala were generated by standard site-
directed mutagenesis protocols and confirmed by plasmid DNA sequencing.
Wild-type and mutant enzymes were purified according to procedures
described earlier (Borisova et al., 2011). Briefly, the plasmids were transformed
into competent E. coli Rosetta2 strain, and recombinant protein expression
was induced by addition of 0.2 mM of isopropyl b-D-1-thiogalactopyranoside
for 16 hr at 18C. The cells were collected by centrifugation and resuspended
in lysis buffer A (20 mM Tris [pH 8.0] 500 mM NaCl, and 10% glycerol). Cells
were lysed by multiple passes through a C5 Avestin cell homogenizer, and
the lysate by clarified by centrifugation. The lysate was loaded on a 5 ml
Ni-NTA column equilibrated in lysis buffer A. The column was extensively
washed with lysis buffer A supplemented with 30 mM imidazole and eluted
by a linear gradient to 200 mM imidazole. Pure protein fractions, as judged
by SDS-PAGE, were pooled and dialyzed in 20 mM Tris (pH 8.9) and
100 mM NaCl for 12 hr. The hexahistidine tag was removed by digestion
with thrombin (1 U/mg of protein) followed by ion exchange chromatography
and size exclusion chromatography (Superdex 75 16/60, GE Healthcare) in
20 mMHEPES (pH 7.5) and 100 mM KCl buffer. The protein was concentrated
using Amicon centrifugal filters. This process routinely yielded 5 mg of highly
pure protein per liter of culture.
The crystals of PhnY were grown at 15C using hanging drop vapor-diffusion
method by mixing 1 ml protein sample at 8 mg/ml concentration, with an equal
volume of reservoir mother liquor. Apo-form crystals were obtained in mother
liquor containing 22%–25% PEG3350, 0.1 M sodium cacodylate (pH 6.5),
0.2 M sodium phosphate dibasic, and 5%–10% glycerol within 2 days and
grew to their maximum size in 1 week. For crystallization of cofactor, substrate,
andproduct complexcocrystals, theproteinwas incubatedwith5mMfinal con-Chemistry & Biology 21, 125centrationofPnAA,PnA,andNAD+, and thesalt inmother liquorwassubstituted
to 0.2 M ammonium chloride. Crystals were cryoprotected by brief soaking in
mother liquor supplemented with 25% glycerol and vitrified in liquid nitrogen.
GAPDH was cloned from Streptococcus mutans Clarke ATCC 25175 and
expressed as an N-terminal His6-fusion protein from a pET15b vector in
E. coli Rosetta2. Cells were grown to an optical density (600 nm) 0.6 in
lysogeny broth, expression was induced with 0.3 mM IPTG at 18C for
16 hr, and cells were harvested by centrifugation. The cell pellet from 1 l of cul-
ture was resuspended in lysis buffer B (50 mM HEPES pH 7.5, 200 mM KCl,
10% glycerol, 5 mM dithiothreitol [DTT], 20 mM imidazole, 10 U DNase, and
25 mg lysozyme), lysed with a French press (15,000 psi), and the lysate was
clarified by centrifugation. The clarified lysate was loaded onto a pre-equili-
brated column with Ni-NTA resin. The column was washed with lysis buffer
B, lysis buffer B with 50 mM imidazole, and lysis buffer B with 250 mM imid-
azole. After concentrating with an Amicon centrifuge filter, the protein buffer
was exchanged to 50 mM HEPES pH 7.5, 200 mM KCl, 10% glycerol, 5 mM
DTT using a NAP-25 filter. This process yielded 60 mg GAPDH/l cell culture.
Phasing and Structure Determination
The structure of PhnY was solved by single wavelength anomalous dispersion
(SAD) using data collected from a crystal of selenomethionine labeled protein.
A 4-fold redundant data set was collected from a single crystal of selenome-
thionine derivatized PhnY to a limiting resolution of 2.2 A˚ (overall Rmerge =
11.7, I/s(I) = 2 in the highest resolution shell) utilizing a Mar 300 CCD detector
(LS-CAT, Sector 21 ID-D, Advanced Photon Source). Data were indexed and
scaled using either the HKL-2000 package (Otwinowski et al., 2003) or XDS
(Kabsch, 2010). Heavy atom sites were determined using HySS and refined
using Phaser, as implemented in the Phenix suite of programs (Zwart et al.,
2008), resulting in an initial Figure of Merit of 0.237. Initial phases were further
improved through cycles of noncrystallographic symmetry averaging resulting
in excellent quality experimental maps. Most of the main chain could be built
using ARP/wARP (Perrakis et al., 1997). The remainder of the model was fitted
using XtalView (McRee, 1999) or Coot (Emsley and Cowtan, 2004), and further
improved by rounds of refinement with REFMAC (Murshudov et al., 1997,
1999) interspersed with rounds of manual building. Final refinement using geo-
metric restraints and noncrystallographic restraints was carried out using the
Phenix package (Zwart et al., 2008). Cross-validation used 5% of the data in
the calculation of the free R factor (Kleywegt and Bru¨nger, 1996).
The cocrystal structures of PhnY in complex with PnAA, PnAA-NAD+, PnA-
NAD+, and G3P-NAD+, were determined, to resolutions of 2.1, 2.0, 2.07, and
2.25 A˚, respectively, by molecular replacement using the coordinates of apo
PhnY as a search probe. Each of the structures was refined and validated
using the procedures detailed above. Cross-validation was routinely used
throughout the course of model building and refinement using 5% of the
data in the calculation of the free R factor. For each of the structures, the ste-
reochemistry of the model wasmonitored throughout the course of refinement
using PROCHECK (Laskowski et al., 1996). Relevant data collection and
refinement statistics are provided in Table 1.
Synthesis of 3-OPP
Following a modified literature procedure (Rudinskas and Hullar, 1976), 2.0 g
(7.5 mmol) of diethyl (3,3-diethoxypropyl)phosphonate was added to a three-
necked flask equipped with a condenser under N2. TMSCl (3.8 ml, 30 mmol)
was added, and the mixture was refluxed for 2 hr. Although residual starting
material was still present, refluxing for longer periods led to an increase in
byproducts, which were difficult to remove. After 2 hr, the mixture was cooled
to 50C, and 2 ml of H2O was added to hydrolyze the residual TMSCl and
deprotect the silyl groups and unmask the aldehyde. The reaction was stirred
for 30 min, H2O (5 ml) was added, and the solvent was removed using a rotary
evaporator to afford a yellow oil. 1H, 31P, and [1H-31P] gHMBC nuclear mag-
netic resonance (NMR) analysis and electrospray ionization-mass spectros-
copy characterization confirmed the presence of both 3-OPP with a small
amount of diethyl (3-oxopropyl)phosphonate as the sole byproduct. Spectral
data for 3-OPP: NMR: 1H (500 MHz, D2O): d 9.52 (s, CHO), 2.72 (dt, J = 14.6,
7.5, PCH2CH2), 2.06 (dt, J = 17.7, 7.5, PCH2CH2);
31P (202 MHz,
D2O): d 35.6 ppm. HR-MS (ESI
+): found 139.0162, calculated 139.0160
(1.4 ppm). 31P NMR analysis of a stock of the 3-OPP mixture with an internal
standard of Pi allowed the determination of the 3-OPP concentration.–135, January 16, 2014 ª2014 Elsevier Ltd All rights reserved 133
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The kinetics of substrate oxidation bywild-type PhnY enzyme and site-specific
mutants were determined by monitoring the reduction of NAD+ using proce-
dures described previously (Borisova et al., 2011). Enzyme (0.1–5 mM depend-
ing on the construct) was incubated with NAD+ in 50 mM HEPES, pH 7.5
supplemented with 10mMMgSO4 for 5min at 30
C. The reaction was initiated
by addition of phosphonate/phosphate substrate. To obtainMichaelis-Menten
kinetics, one substrate was maintained at saturating levels while the other
substrate was varied; rates were obtained in triplicate. The Cys291Ala and
Glu254Ala mutant enzymes were assayed at various substrate and enzyme
concentrations. One mutant, Glu385Ala, displayed substrate inhibition and
its kinetic parameters were obtained by fitting to the appropriate equation,
v = kcat[E][S]/[Km,s +[S]+([S]
2/Ki,s)], where [E] is the enzyme concentration, [S]
is the substrate concentration, and Ki,s is the inhibition constant of the sub-
strate. A similar procedure was used for the kinetic studies with GAPDH
(0.02–20 mM depending on the substrate) except that the buffer used was
50 mM HEPES pH 8.0 supplemented with 5 mM DTT and the cofactor used
was NADP+.
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